The Role of Disturbances in Vaginal Microbiocenosis in Recurrent Urogenital Candidiasis
DOI:
https://doi.org/10.48112/acmr.v5i1.66Keywords:
Recurrent urogenital candidiasis, vaginal microbiocenosis, PCR diagnostics, dysbiosis, antifungal therapyAbstract
Abstract Views: 21
Purpose: This study aims to investigate the role of disturbances in vaginal microbiocenosis in recurrent urogenital candidiasis (UGC), focusing on the type of fungus present and the bacterial mass, using PCR diagnostics. Methods: Twenty-two women diagnosed with chronic vulvovaginal candidiasis were examined. PCR diagnostics, including the Mycoso-Screen analysis for fungal pathogens and the Femoflor-16 PCR test system for vaginal dysbiosis, were performed to determine the type of fungus and bacterial mass present. Results: Candida albicans was found in 36% of patients, Candida glabrata in 32%, Debaryomyces hansenii in 12%, Pichia kudriavzevii in 12%, and Saccharomyces cerevisiae in 12%. Moreover, dysbiosis of vaginal microbiota was observed in 77% of patients, characterized by decreased lactobacilli and increased opportunistic microflora, contributing to the recurrence of UGC. Conclusion: Recurrent urogenital candidiasis is influenced by various factors, including the properties of yeast fungi and disturbances in vaginal microbiota. Comprehensive treatment addressing both fungal and bacterial components of dysbiosis may provide better therapeutic outcomes and reduce the recurrence of UGC. Further research is warranted to elucidate the mechanisms underlying these interactions and optimize treatment strategies.
References
de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1. doi: 10.1186/1471-2334-2-1.
Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014;289(3):479-89. doi: 10.1007/s00404-013-3064-9.
Coudeyras S, Jugie G, Vermerie M, Forestier C. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol. 2008;2008:549640. doi: 10.1155/2008/549640.
Ehrström S, Daroczy K, Rylander E, Samuelsson C, Johannesson U, Anzén B, et al. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect. 2010;12(10):691-9. doi: 10.1016/j.micinf.2010.04.010.
Zárate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol. 2006;43(2):174-80. doi: 10.1111/j.1472-765X.2006.01934.x.
Reid G, Kim SO, Köhler GA. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol Med Microbiol. 2006;46(2):149-57. doi: 10.1111/j.1574-695X.2005.00026.x.
ACOG Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis. Obstet Gynecol. 2006;107(5):1195-1206. doi: 10.1097/00006250-200605000-00049.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Advances in Clinical Medical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI-PMH 
